2023
The association between exposome score for schizophrenia and metabolic parameters in individuals with schizophrenia and healthy controls: Findings from the EUGEI study
Erzin G, Atbaşoğlu C, Fusar-Poli L, Saka M, Üçok A, Alptekin K, Os J, Akay G, Gülöksüz S. The association between exposome score for schizophrenia and metabolic parameters in individuals with schizophrenia and healthy controls: Findings from the EUGEI study. European Psychiatry 2023, 66: s264-s264. PMCID: PMC10596217, DOI: 10.1192/j.eurpsy.2023.601.Peer-Reviewed Original ResearchMetabolic parametersHealthy controlsES-SCZHigh-density lipid levelsDiastolic blood pressureNational Schizophrenia NetworksExposome scorePhysical health outcomesBlood pressureAnalysis ageLipid levelsGlucose levelsGene-environment interactionsPsychosis developmentLinear regression analysisHealth outcomesPrenatal periodSchizophrenia NetworkSchizophreniaClinical implementationEnvironmental exposuresEUGEI studyNongenetic exposuresRegression analysisImportant metabolic parameters
2022
Exposome and Trans-syndromal Developmental Trajectories Toward Psychosis
Barzilay R, Pries L, Moore T, Gur R, van Os J, Rutten B, Guloksuz S. Exposome and Trans-syndromal Developmental Trajectories Toward Psychosis. Biological Psychiatry Global Open Science 2022, 2: 197-205. PMID: 36325037, PMCID: PMC9616341, DOI: 10.1016/j.bpsgos.2022.05.001.Peer-Reviewed Original ResearchEnvironmental exposuresEarly life environmental exposuresNonspecific clinical presentationClinical presentationTrajectories of riskClinical settingPrenatal periodMental healthDevelopmental cohortGenetic factorsEarly childhoodYounger cohortsCategorical outcomesSensitive periodCohortDevelopmental disordersAdolescent psychopathology